TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Hutchmed
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting

HUTCHMED will present clinical data on multiple compounds at two major medical conferences, including studies on fruquintinib, HMPL-A83, savolitinib, surufatinib, and sovleplenib across various cancer and medical conditions.

Insights
HCM   positive

Company is presenting multiple promising clinical trial results across diverse therapeutic areas, indicating active research and development pipeline